




Searching News Database: DUSA Pharmaceuticals
HSMN NewsFeed - 11 May 2009
DUSA Initiates Clinical Trial of Levulan(R) PDT on High-Risk Solid Organ Transplant Recipients
DUSA Initiates Clinical Trial of Levulan(R) PDT on High-Risk Solid Organ Transplant Recipients
HSMN NewsFeed - 21 Apr 2008
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness
HSMN NewsFeed - 29 Oct 2007
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
HSMN NewsFeed - 8 Oct 2007
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
HSMN NewsFeed - 14 Jun 2007
DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
HSMN NewsFeed - 17 May 2007
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
HSMN NewsFeed - 21 Jun 2006
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
HSMN NewsFeed - 15 Jun 2006
DUSA Pharmaceuticals Announces Election of Robert F. Doman to Board of Directors
DUSA Pharmaceuticals Announces Election of Robert F. Doman to Board of Directors
HSMN NewsFeed - 15 May 2006
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
HSMN NewsFeed - 10 Apr 2006
DUSA Announces Hiring of William F. O'Dell as Executive Vice President, Sales and Marketing
DUSA Announces Hiring of William F. O'Dell as Executive Vice President, Sales and Marketing
HSMN NewsFeed - 1 Feb 2006
Dusa Pharmaceuticals Reports Results from Phase II Clinical Trial for PDT of Moderate to Severe Acne
Dusa Pharmaceuticals Reports Results from Phase II Clinical Trial for PDT of Moderate to Severe Acne
HSMN NewsFeed - 3 Jan 2006
DUSA Pharmaceuticals Signs Merger Agreement To Acquire Sirius Laboratories
DUSA Pharmaceuticals Signs Merger Agreement To Acquire Sirius Laboratories
Additional items found! 15

Members Archive contains
15 additional stories matching:
DUSA Pharmaceuticals
(Password required)
DUSA Pharmaceuticals
(Password required)